Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
Zerbe LK, Dwyer-Nield LD, Fritz JM, Redente EF, Shroyer RJ, Conklin E, Kane S, Tucker C, Eckhardt SG, Gustafson DL, Iwata KK, Malkinson AM.
Zerbe LK, et al. Among authors: gustafson dl.
Cancer Chemother Pharmacol. 2008 Sep;62(4):605-20. doi: 10.1007/s00280-007-0644-z. Epub 2007 Nov 21.
Cancer Chemother Pharmacol. 2008.
PMID: 18030469